Evidence map›Paper›PMID 35834243›Full record

ArticleAmerican journal of hematology2022

Human papilloma virus vaccine and VITT antibody induction.

Adam J Kanack, Ingvild J Laegreid, Silje Johansen, Håkon Reikvam, Maria T Ahlen, Anand Padmanabhan

Abstract readLetter
In one paragraph

Article in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Anti-Platelet factor 4 immunothrombosis-not just heparin and vaccine triggers.Research and practice in thrombosis and haemostasis · 2025
    Review
  7. Review
  8. Demystifying autoimmune HIT: what it is, when to test, and how to treat.Hematology. American Society of Hematology. Education Program · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Vaccine-induced immune thrombotic thrombocytopenia.Best practice & research. Clinical haematology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam J KanackDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-6077-0475
Ingvild J LaegreidThe Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromso, Norway.ORCID 0000-0002-6379-4018
Silje JohansenSection of Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Håkon ReikvamSection of Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Maria T AhlenThe Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromso, Norway.
Anand PadmanabhanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2519-4377

Funding

New approaches to the pathophysiology, diagnosis and management of heparin-induced thrombocytopeniaR01HL158932 · NHLBI · MAYO CLINIC ROCHESTER · PI PADMANABHAN, ANAND · 2021 to 2025
$2.0M
NHLBI NIH HHS R01 HL158932
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Papillomavirus VaccinesAntibodiesHumansVaccinationAntibodiesPapillomavirus Vaccines

Identifiers

PMID35834243
PMCPMC9463111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.